Drs. Baer, Rassool and Tomkinson recently have been awarded a V Foundation grant to study DNA repair pathways in leukemia.
Ronald Gartenhaus, M.D., Associate Professor, Department of Medicine, has published an article in the October 1, 2009 issue of the Cancer Research Journalentitled “ERK Positively Regulates the Oncogenic Activity of MCT-1 in Diffuse Large B-Cell Lymphoma.”
Xiao-Ling Li, Ph.D., Research Associate, Department of Microbiology and Immunology received the 2009 Milstein Young Investigator Award from the International Society for Interferon and Cytokine Research. The award was presented at the ISICR Annual Meeting in Lisbon, Portugal, where Dr. Li presented her work entitled: "Reciprocal Regulation of Tristetraproline and RNase-L Modulates the Induction of Proinflammatory Cytokines"
Ronald Gartenhaus, M.D., Associate Professor, Department of Medicine, has been appointed co-leader of the Molecular and Structural Biology Program in the Cancer Center.
Koji Tamada, M.D., Ph.D., Associate Professor, Department of Otorhinolarynology and member of the Program in Oncology has been appointed co-leader of the Tumor Immunology and Immunotheraphy Program in the Cancer Center.
Ming T. Tan, Ph.D., Professor, Department of Epidemiology and Preventive Medicine, has been invited to present at the NCI Translational Science Meeting 2 held in Vienna, Virginia, November 5-6 on the design and analysis of drug synergy in therapeutic development: applications to Vorinostat with cystosine arabinoside and etopside and other combination studies. His collaborators include Drs. Hongbin Fang, Douglas Ross, Martin Edelman and Edward Sausville.
Ronald Gartenhaus, M.D., Associate Professor, Departments of Medicine and Molecular Microbiology & Immunology and member of the Program in Oncology received an NIAAA R01grant from the National Institutes of Health for his work entitled “Alcohol Consumption and Risk of NHL: Role of mTOR Dysfunction” in the amount of $1,781,250 for the period September 5, 2009 to August 31, 2014.
Feyruz Rassool, Ph.D., Associate Professor, Department of Radiology, has been awarded a V Foundation grant, “Targeting abnormal DNA repair pathways in leukemia” in the amount of $600,000 (total costs) for the period of September 1, 2009 to August 31, 2012.
Anne Hamburger, Ph.D., Professor, Department of Pathology and member of the Program in Oncology, has been awarded a NCI grant, “A novel therapy for HER2 positive hormone refractory breast cancer” in the amount of $930,338 (total costs) for the period of September 30, 2009 to August 31, 2011.
Kevin J. Cullen, M.D., Director, UMGCC received two administrative supplements to the Cancer Center Support Grant (P30). One to hire a new physician-scientist in the amount of $1,500,000 for the period of August 1, 2009 to July 31, 2010 and the second for pilot and grant programs to support developing shared services in the amount of $150,000 for the period of September 1, 2009 to August 31, 2011.
Amy S. Kimball, M.D., Ph.D., has joined the University of Maryland Marlene and Stewart Greenebaum Cancer Center (UMGCC) Hematologic Malignancies Program and was appointed Clinical Assistant Professor of Medicine, University of Maryland School of Medicine. Dr. Kimball graduated from the University of California at Santa Cruz with a B.A in biology with honors. She earned a Ph.D. in biology from Johns Hopkins University, and received her medical degree from the University of Maryland School of Medicine. Dr. Kimball completed her residency in internal medicine at Sinai Hospital and is board certified in internal medicine. She also completed a fellowship in hematology and medical oncology at UMGCC. Dr. Kimball will specialize in treating patients with lymphoma and will focus her research efforts on further developing the cancer center's lymphoma clinical trials and translational research program.